Methotrexate Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-122

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 63323-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Met17 0001 01

Chemical structure of Methotrexate showing the molecular arrangement including pteridine, para-aminobenzoic acid, and glutamic acid sections typical for this active ingredient.*

FDA Label Image

Met17 0001 02

FDA Label Image

Met17 0001 03

Label for Methotrexate for Injection, USP, 1 gram per vial, sterile and lyophilized. The label indicates the product is preservative free and cytotoxic. It includes storage instructions, warnings, and notes that it is a single dose vial from Fresenius Kabi USA, LLC, with NDC 63323-122.*

FDA Label Image

Met17 0001 04

Methotrexate for Injection, USP 1 gram per vial, single dose vial. The label notes the product is preservative free and a cytotoxic agent. It includes instructions to see the package insert for routes of administration. The labeler is Fresenius Kabi USA, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.